Clinical Trial Update: Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial NCT03828123 completed its Phase 1/2 study of autologous multipotent mesenchymal stromal cells in amyotrophic lateral sclerosis. The sponsor is Bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Autologous Multipotent Mesenchymal Stromal Cells (mesenchymal stromal cells)

Snippet

Sponsor: Bioinova, s.r.o. | Conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED